关于肌缩侧面硬化症生物标志物的综述:一种病理生理学方法
Rawiah S Alshehri1, Ahmad R Abuzinadah2,3, Moafaq S Alrawaili2,3
1Department of Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah 22252, Saudi Arabia.
International journal of molecular sciences
|October 26, 2024
概括
肌缩侧面硬化症 (ALS) 的研究寻求客观的生物标志物. 与其他生物流体标志物相比,神经纤维在ALS患者中显示出神经退行症的优异指标.
科学领域:
- 神经学 神经学
- 生物标志物发现发现
- 神经退行研究 神经退行研究
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种复杂的神经退行性疾病,影响运动神经元.
- 由于ALS的异质性,对诊断,预后和治疗开发构成了挑战.
- 当前的诊断和监测工具 (功能尺度,电生理学) 有局限性.
研究的目的:
- 审查ALS的定量生物流体生物标志物.
- 评估各种生物标志物的实用性和局限性.
- 突出神经纤维作为ALS中优越的神经退行标记物.
主要方法:
- 对ALS的定量生物流体生物标志物临床研究的病理生理学综述.
- 对反映蛋白质聚合和肌肉脱皮的生物标志物的分析.
- 对不同候选生物标志物的比较评估.
主要成果:
- 目前没有生物标志物被验证用于临床治疗ALS.
- 已经研究了各种生物流体生物标志物,反映了不同的疾病过程.
- 神经纤维在其他生物标志物上表现出优越性,用于表明ALS的神经退行.
结论:
- 需要对ALS进行客观定量生物流体生物标志物.
- 神经纤维是追踪ALS神经退行症的有希望的生物标志物.
- 需要进一步验证ALS生物标志物的临床应用.
相关概念视频
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


